Extra Pfizer vaccine doses bring hope to embattled hospital workers
The discovery means that hundreds more doctors, nurses and support staff like police officers and custodians at Cleveland MetroHealth could get vaccinated early.
Pfizer
Extra Pfizer vaccine doses spur optimism
The FDA granted emergency authorization to Moderna's vaccine. An initial batch of six million doses will begin shipping out this weekend, and Moderna says it hopes to make up to 100 million doses available in the U.S. by March. It comes one week after the approval of Pfizer’s vaccine, which is already being administered. Errol Barnett was the first to report that some vials of the Pfizer vaccine contained extra doses, and is now showing how that was enough to vaccinate even more health care workers and staff at one Cleveland hospital.
FDA panel endorses moderna's coronavirus vaccine
An FDA advisory panel has recommended emergency use of Moderna's coronavirus vaccine. The FDA could authorize the vaccine as early as Friday and six million doses could be shipped out next week. This comes as the total number of cases in the U.S. tops 17 million and California becomes the epicenter of the nation's outbreak. Dr. Yves Duroseau, chair of the Department of Emergency Medicine at Lenox Hill Hospital, joins CBSN to discuss how the vaccines work.
FDA panel votes for Moderna vaccine
A Food and Drug Administration advisory panel voted to recommend Moderna's COVID-19 vaccine for emergency use authorization on Thursday. Meanwhile the rollout of Pfizer's vaccine to frontline health care workers continues. Columbia University professor of epidemiology and medicine Dr. Wafaa El-Sadr joins CBSN's "Red & Blue" anchor Elaine Quijano with more on what the safety data shows.
FDA panel endorses Moderna's COVID vaccine
A second coronavirus vaccine could begin shipping this weekend that will provide millions of additional doses to Americans. This comes as the U.S. sets another deadly record as the pandemic surges. Jonathan Vigliotti reports.
Extra doses found in Pfizer vaccine vials
Vials of Pfizer's COVID vaccine were found to contain an extra dose as a second vaccine is on its way to approval. Errol Barnett has more.
Pfizer vaccine vials contain excess doses, surprising hospitals and pharmacists
The FDA and Pfizer have given slightly different advice on how the extra doses should be used — or not used.
Doctor answers questions on COVID vaccines
Members of an FDA advisory panel voted 20-0 to recommend Moderna's COVID-19 vaccine for emergency use. The FDA could authorize it within days, along with the Pfizer vaccine that health care workers started receiving this week. CBS New York's Dr. Max Gomez answers some common questions about the new vaccines on CBSN NY.
FDA panel looks at Moderna's COVID vaccine
The FDA is considering emergency authorization for the Moderna coronavirus vaccine, as the nation continues to break records for daily new cases and deaths. Jennifer Gommerman, a professor of immunology at the University of Toronto, joins CBSN to talk more about the Moderna vaccine and the latest developments with the Pfizer doses.
COVID vaccination effort ramps up in the U.S.
A second COVID-19 vaccine by Moderna could inch closer to approval in the U.S. on Thursday. The Pfizer vaccine is already being distributed at hospitals and nursing homes across the country. The massive vaccination effort comes as the number of new COVID-19 infections continues to break records in the U.S. David Begnaud reports.
Pfizer vials contain extra vaccine doses
Doctors across the nation this week expected to receive the Pfizer vaccine with five doses in each vial. But to their surprise, they've found there may be more full doses available in each vial than previously thought. Errol Barnett reports.
FDA considers Moderna vaccine
Food and Drug Administration advisers are holding a key meeting Thursday to consider approving Moderna's coronavirus vaccine candidate for emergency use. CBS News correspondent David Begnaud and internal medicine physician Dr. Shoshana Ungerleider join CBSN with the latest on the United States' dire fight against the deadly disease, including extra doses in Pfizer's vaccine vials as well as concerns about rare allergic reactions.
Could Big Pharma cash in on COVID vaccine?
Pfizer and Moderna could be looking at a big check once their first round of COVID vaccines are distributed, despite a non-lucrative market and pressure to keep costs low. But the key for both companies may lie in the patenting process. Quartz reporter Annalisa Merelli joined CBSN AM to explain how the COVID vaccine compares to other vaccines on the market and why the mRNA patent could have larger implications outside of coronavirus. She also gave insight to life inside Bergamo, Italy, one of the hardest-hit town earlier on in the pandemic.
FDA clears way for second COVID-19 vaccine
By the end of the week, the U.S. could have two approved COVID-19 vaccines. The first, by Pfizer, is already being administered to frontline health care workers across the nation. "CBS This Morning" lead national correspondent David Begnaud got an exclusive look as nearly 5,000 doses arrived at the UC Davis Medical Center in Sacramento, California.
COVID vaccinations ramp up in U.S.
Americans start to get vaccinated against COVID-19 as deaths cross 300,000. Dr. David Agus joins "CBS This Morning" to explain the process, and how long it will take.
Vaccine researcher: Virus fight is personal
Kathrin Jansen saw the deadly impact of COVID-19 in New York and it fueled her desire to develop a vaccine. 60 Minutes reports, Sunday.
U.S. nears 17 million cases as vaccine rollout expands
A second coronavirus vaccine could be made available in the U.S. as early as this week. The FDA is expected to authorize Moderna's vaccine for emergency use as cases skyrocket this holiday season. Dr. Leo Nissola is a medical expert and immunotherapy scientist. He joined CBSN to discuss the latest.
ICU nurse shares COVID-19 vaccination experience
Doses of Pfizer's COVID-19 vaccine have been distributed across the U.S., and health care workers are among the first to be vaccinated. Casey Pickering is an ICU nurse manager for the Kansas University Health System and was among the first of the medical staff to get vaccinated there. They joined CBSN to discuss.
Health care workers feel spark of hope as vaccinations begin
The FDA said the Moderna vaccine overall is 94.5% effective and 100% effective in people 65 and over.
FDA says Moderna vaccine is highly effective
Moderna's coronavirus vaccine could soon be part of America's largest mass vaccination effort. The Food and Drug Administration said the vaccine is highly effective and there are "no specific safety concerns," and a panel is expected to consider the pharmaceutical company's application for emergency use this week. This comes as distribution ramps up for Pfizer's vaccine and health care systems are stretched thin as coronavirus infections skyrocket. CBS News correspondent Mola Lenghi reports on the latest developments from New York City, CBS News chief congressional correspondent Nancy Cordes reports from Washington on the need for funding to fight COVID-19, and Dr. Richard Besser, president and CEO of the Robert Wood Johnson Foundation and the former acting director of the Centers for Disease Control and Prevention, joined CBSN to discuss.
FDA panel to discuss Moderna vaccine Thursday
The U.S. could be days away from authorizing a second coronavirus vaccine as both coasts see cases surge. CBS News correspondent David Begnaud reports on California hospitals grappling with a rising infection rate and Dr. Neeta Ogden, internal medicine specialist and immunologist, joined CBSN to discuss the how some states are struggling with vaccine funding and the Food and Drug Administration's authorization of the first over-the-counter rapid test.
Doctor on COVID vaccines and staying vigilant
A massive nationwide vaccination effort has begun in the U.S. as hospitals continue filling up with COVID-19 patients fighting for their lives. The nation has surpassed 300,00 deaths from the virus. Dr. Uché Blackstock joins CBSN to talk about the Pfizer and Moderna vaccines and what Americans need to do to fight the pandemic in the meantime.
U.S. ramps up vaccine rollout
The U.S. is ramping up its vaccine rollout, as the country surpasses 300,000 virus-related deaths and the Food and Drug Administration clears a path for a second vaccine, by Moderna. CBS News correspondent David Begnaud reports on the second day of the rollout as the virus arrives at some hospitals and Dr. Dyan Hes, founder of Gramercy Pediatrics, joined CBSN to discuss vaccines for children and pregnant women, coronavirus mutations and more.
Pfizer vaccine research chief says fight against COVID-19 is personal
Kathrin Jansen saw the deadly impact of COVID-19 in New York and it fueled her desire to develop a vaccine. 60 Minutes reports, Sunday.
U.S. administers first doses of COVID vaccine
Frontline workers across the U.S. lined up to get their first doses of the coronavirus vaccine. Mola Lenghi has the latest.
Tennessee prison system head to resign after failed Christa Pike execution
Jane Doe's attorney says "she was incapable of consent," alleges cover-up
Medical plane missing near Nantucket with 6 on board, authorities say
Live
Senior Trump administration officials met to discuss Iran war at Camp David
Iowa approves pricy foreign-owned steel plant project in swing district
More details emerge about FlyDubai co-pilot who tried to crash plane
U.K. police accuse 2 Iranian men of planning terror attack on Jewish community
Judge says federal law banning noncitizen voting is unconstitutional
